Clinical Drug Investigation

Dose and Frequency of Administration of Interferon- Affect its Efficacy in Multiple Sclerosis
pp. 551-559(9)
Author: Sharief M.K.

Clinical Benefits with Oseltamivir in Treating Influenza in Adult Populations: Results of a Pooled and Subgroup Analysis
pp. 561-569(9)
Authors: Singh S.; Barghoorn J.; Bagdonas A.; Adler J.; Treanor J.; Kinnersley N.; Ward P.

Long-Term Cost Effectiveness of Interferon--1a in the Treatment of Relapsing-Remitting Multiple Sclerosis: An Econometric Model
pp. 571-581(11)
Authors: Lepen C.; Coyle P.; Vollmer T.; Blumhardt L.; Lilliu H.; Beresniak A.

Managing Hypertension with Combination Diuretics and Methyldopa in Nigerian Blacks at the Primary Care Level
pp. 583-590(8)
Authors: Erhun W.O.; Agbani E.O.; Bolaji E.E.

Efficacy of Pefloxacin in the Treatment of Patients with Acute Infectious Diarrhoea
pp. 591-596(6)
Authors: Troselj-Vukic B.; Poljak I.; Milotic I.; Slavic I.; Nikolic N.; Morovic M.

Efficacy and Safety of Ketotifen Eye Drops as Adjunctive Therapy to Mometasone Nasal Spray in Subjects with Seasonal Allergic Rhinoconjunctivitis
pp. 597-604(8)
Authors: Horak F.; Stuebner P.; Zieglmayer R.; McWhirter C.L.; Gekkieva M.

Pharmacokinetic-Pharmacodynamic Modelling of Ketamine in Six Neurotraumatised Intensive Care Patients
pp. 605-609(5)
Authors: Hijazi Y.; Bodonian C.; Salord F.; Bressolle F.; Boulieu R.

Reversibility of Tacrolimus-Induced Alopecia: A Case Report and Literature Review
pp. 611-614(4)
Authors: Chan A.L.F.; Wang H-Y.

Bilateral Skin Ulceration after Injection of Pegylated Interferon--2b in a Patient with Chronic Hepatitis C
pp. 615-619(5)
Authors: Gallelli L.; Guadagnino V.; Caroleo B.; Marigliano N.; De Sarro G.B.; Izzi A.